b

Clinicians & children with #cancer report symptom burden differently: clinicians consistently downgrade symptoms. Dr. Bryce Reeve & team find enhancing the child’s voice through surveys can improve cancer care and identify effective treatments. bit.ly/3Lz7fKx

We need to listen to parental and child voices when we determine what it means to be eligible for a clinical trial. Proud to work w @duke_pophealth @SharonCastelli2 @justinnbaker et al. @ChildrensPgh @PittPediatrics @PedsHemeOncPGH #pedpc acsjournals.onlinelibrary.wiley.com/doi/abs/10.100…

Looking forward to our chat with the FDA tomorrow about the Pediatric PRO-CTCAE system to capture the child's voice in self-reporting symptomatic AEs while undergoing cancer treatment. #PRO fda.gov/advisory-commi…

@JohnMSalsmanPhD Thanks, I haven't learned the hashtag thing yet. 🙂

#PedOnc #PedCSM #Cancer #PROs #PROMs

FDA identified only 4 out of 17 commercial pediatric oncology trials (1997-2020) included PROs (in single arm trials, with PRO as exploratory endpoint). FDA makes a strong recommendation for inclusion of PROs to capture the child's voice. academic.oup.com/jnci/advance-a…

@TheresaColes20 @ISPORorg Congrats, Theresa! I look forward to hearing how the class went.

@ISPORorg I really enjoyed teaching this year! Thank you to all the participants. What fantastic, thoughtful questions!

There’s still time to learn about the range & scope of PRO measures in “Introduction to Patient-Reported Outcomes Assessment: Instrument Development & Evaluation,” tomorrow, 4/28-29 at 8:00AM EDT. Faculty: Theresa Coles, PhD. #HEOR Learn more>> ow.ly/cpy050EzdsV

@arlenechung Congratulations, Arlene! Well deserved.

Wanted to share the belated great news! Awarded tenure and promotion to Associate Professor at UNC. So grateful to the village of people who have supported, encouraged, and helped me along the way to grow as a physician scientist, informatician, educator, leader, and person!